F121Y

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
OBJECTIVES Integrase strand transfer inhibitor (INSTI) is a new class of antiretroviral (ARV) drugs designed to block the action… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2015
2015
OBJECTIVES Strand transfer inhibitors (raltegravir, elvitegravir and dolutegravir) are now commonly used to inhibit HIV-1… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2014
2014
This July 2014 edition of the IAS-USA drug resistance mutations list updates the figures last published in March 2013. The… (More)
Is this relevant?
2014
2014
OBJECTIVES The possibility of replacing raltegravir or elvitegravir with dolutegravir in heavily treatment-experienced patients… (More)
  • table 1
  • figure 1
Is this relevant?
2012
2012
Raltegravir is an integrase inhibitor (INI) licensed for clinical use and other INI are in advanced stage of development… (More)
Is this relevant?
2012
2012
Elvitegravir is a strand transfer inhibitor of HIV-1 integrase that is currently undergoing phase 3 clinical testing. The two… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
2012
2012
OBJECTIVES To investigate the best conditions of raltegravir use to avoid the selection of resistance mutations in the three main… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?